Skip to Main Content

Author Details

Bülent Arman Aksoy
2012
37
25
PMIDPaper TitleJournal TitlePublished Year
36472581The Combination of TIM3-Based Checkpoint Blockade and Oncolytic Virotherapy Regresses Established Solid Tumors.Journal of Immunotherapy2023
37801615Progressively enhancing stemness of adoptively transferred T cells with PI3Kδ blockade improves metabolism and anti-tumor immunity.2023
32581062Initial dose of oncolytic myxoma virus programs durable antitumor immunity independent of in vivo viral replication.Journal for ImmunoTherapy of Cancer2020
31647099Pathway Commons 2019 Update: integration, analysis and exploration of pathway data.Nucleic Acids Res2020
31239316Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control.Cancer Immunol Res2019
31477013Cytokit: a single-cell analysis toolkit for high dimensional fluorescent microscopy imaging.BMC Bioinformatics2019
30694219T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy.J Clin Invest2019
31417090Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis.Nat Commun2019
29396322A Landscape of Metabolic Variation across Tumor Types.Cell Syst2018
30172842Coral: Clear and Customizable Visualization of Human Kinome Data.Cell Syst2018
30108106<i>KMT2C</i> Mutations in Diffuse-Type Gastric Adenocarcinoma Promote Epithelial-to-Mesenchymal Transition.Clin Cancer Res2018
30590044Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in Cancer.Cell Reports2018
29357823Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer.BMC Cancer2018
27956380Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade.Cancer Immunol Res2017
28552987Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis.PLoS Med2017
29033940PI3Kδ Inhibition Enhances the Antitumor Fitness of Adoptively Transferred CD8 T Cells.Frontiers in Immunology2017
29220450CTD2 Dashboard: a searchable web interface to connect validated results from the Cancer Target Discovery and Development Network.Database (Oxford)2017
29403468Computational Pipeline for the PGV-001 Neoantigen Vaccine Trial.Frontiers in Immunology2017
26685306PaxtoolsR: pathway analysis in R using Pathway Commons.Bioinformatics2016
27153605pileup.js: a JavaScript library for interactive and in-browser visualization of genomic data.2016
26766592An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma.Cancer Cell2016
26482039Chemotherapy Resistance in Diffuse-Type Gastric Adenocarcinoma Is Mediated by RhoA Activation in Cancer Stem-Like Cells.Clin Cancer Res2016
26061751Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.N Engl J Med2015
25887147Systematic identification of cancer driving signaling pathways based on mutual exclusivity of genomic alterations.Genome Biol2015
27135912Pan-Cancer Analysis of Mutation Hotspots in Protein Domains.Cell Syst2015
26030594SBGNViz: A Tool for Visualization and Complexity Management of SBGN Process Description Maps.PLoS One2015
26284497Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells.Elife2015
25086704Integrating biological pathways and genomic profiles with ChiBE 2.BMC Genomics2014
24045775Pattern search in BioPAX models.Bioinformatics2014
24665131Prediction of individualized therapeutic vulnerabilities in cancer from genomic profiles.Bioinformatics2014
23504936Using MEMo to discover mutual exclusivity modules in cancer.Curr Protoc Bioinformatics2013
23550210Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.Sci Signal2013
23749186Genome-wide inference of natural selection on human transcription factor binding sites.Nature Genetics2013
24068901Using biological pathway data with paxtools.PLoS Comput Biol2013
24071851Emerging landscape of oncogenic signatures across human cancers.Nat Genet2013
23766416PiHelper: an open source framework for drug-target and antibody-target data.Bioinformatics2013
22588877The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data.Cancer Discov2012
  • 1 - 37 of 37

Recommended Authors

Collaborators

Broad Institute of MIT and Harvard
Co-authored papers 19
Memorial Sloan Kettering Cancer Center
Co-authored papers 12
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 10
Houston Methodist Research Institute
Co-authored papers 9
Co-authored papers 7
University of Lausanne (UNIL)
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Dana-Farber Cancer Institute
Co-authored papers 5
Bilkent University
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Harvard Medical School
Co-authored papers 4
Co-authored papers 4
Co-authored papers 2
University of Toronto
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 2
Co-authored papers 1
Nationwide Children's Hospital
Co-authored papers 1
Co-authored papers 1
University of North Carolina at Chapel Hill
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
The University of MD Anderson Cancer Center
Co-authored papers 1
University of Texas MD Anderson Cancer Center
Co-authored papers 1